PFIZER Archives

Anti-Obesity Drugs – Pharma Companies Race to Grab a Bite of the Pie

16/07/2025by EOS Intelligence

For many years, bariatric surgery has been the go-to option for people struggling with obesity and obesity-induced conditions. However, for the last couple of years, another easier option has become...

New Directions in Alzheimer’s Diagnostics: Will Blood Tests Replace CSF and PET?

30/09/2024by EOS Intelligence

Around three-fourths of dementia cases continue to remain undiagnosed even though the incidence of Alzheimer’s disease (AD) is rapidly growing across the globe. AD affects about 60-80% of dementia patients...

Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?

26/09/2024by EOS Intelligence

Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are developing drugs for Alzheimer’s disease (AD) that are currently in...

IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?

20/06/2024by EOS Intelligence

The market reaction to the US Inflation Reduction Act of 2022 is mostly mixed. It is expected to change the pharma industry dynamics in terms of the competitive positioning and...

Vaccines in Africa: Pursuit of Reducing Over-Dependence on Imports

21/02/2024by EOS Intelligence

Pandemics such as COVID-19, Ebola, and the 2009 influenza instilled the need for a well-equipped domestic vaccine manufacturing industry in the minds of African leaders. Currently, due to insufficient local...

Who We Are

Connect With Us

Work With EOS